Faheem Hasnain, SVP, Oncology SBU at BIOGEN IDEC INC (BIIB), sold 11,244 shares at $44.63 ($502K) on 2006-10-02, disclosed to the SEC on 2006-10-03.
Scheduled sale ($502k) by SVP, Oncology SBU under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.55 | 2,000 | $89K | 17.8% |
| 2 | $44.58 | 1,500 | $67K | 13.3% |
| 3 | $44.60 | 1,500 | $67K | 13.3% |
| 4 | $44.63 | 3,000 | $134K | 26.7% |
| 5 | $44.70 | 3,244 | $145K | 28.9% |
| Total | $44.63 avg | 11,244 |
| $502K |
| 100% |
| Filing → |
| GOSS | BUY | 2024-06-24 | $498K | — | Filing → |
| GOSS | SELL | 2024-03-28 | $27K | — | Filing → |
| MRTX | BUY | 2023-08-14 | $600K | — | Filing → |